We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Consumer Discretionary 14.86%
3 Financials 14.2%
4 Technology 12.51%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEN icon
1001
Franklin Resources
BEN
$17.2B
$26.4M 0.01%
790,160
+18,190
+2% +$661K
HLIT icon
1002
Harmonic Inc
HLIT
$1.46B
$26.4M 0.01%
9,248,183
+6,225,906
+206% +$19.1M
P
1003
DELISTED
Pandora Media Inc
P
$26.3M 0.01%
2,114,538
-593,325
-22% -$6.17M
MSI icon
1004
Motorola Solutions
MSI
$77.2B
$26.3M 0.01%
398,856
-1,720
-0.4% -$122K
XOXO
1005
DELISTED
Xo Group Inc
XOXO
$26.3M 0.01%
1,508,902
+96,086
+7% +$1.62M
HEI.A icon
1006
HEICO Corp Class A
HEI.A
$37.5B
$26.3M 0.01%
1,195,461
+40,734
+4% +$860K
AAT
1007
American Assets Trust
AAT
$1.41B
$26M 0.01%
613,410
-21,700
-3% -$871K
CALD
1008
DELISTED
Callidus Software, Inc.
CALD
$26M 0.01%
1,301,650
+51,690
+4% +$934K
LOB icon
1009
Live Oak Bancshares
LOB
$2B
$25.5M 0.01%
1,805,570
+535,876
+42% +$8.17M
LIND icon
1010
Lindblad Expeditions
LIND
$2.26B
$25.5M 0.01%
2,643,370
+20,618
+0.8% +$202K
FMX icon
1011
Fomento Económico Mexicano
FMX
$40B
$25.4M 0.01%
274,360
-415
-0.2% -$37.9K
RSG icon
1012
Republic Services
RSG
$66.2B
$25.4M 0.01%
494,365
+8,592
+2% +$412K
AGFS
1013
DELISTED
AgroFresh Solutions Inc
AGFS
$25.4M 0.01%
4,775,497
+981,138
+26% +$5.46M
OSG
1014
DELISTED
Overseas Shipholding Group Inc.
OSG
$25.3M 0.01%
2,303,182
+580,839
+34% +$6.71M
CVE icon
1015
Cenovus Energy
CVE
$55.6B
$25.2M 0.01%
1,828,650
-613,400
-25% -$8.88M
ULH icon
1016
Universal Logistics Holdings
ULH
$514M
$25.1M 0.01%
1,944,530
+160,077
+9% +$2.31M
RF icon
1017
Regions Financial
RF
$27.1B
$25M 0.01%
2,942,260
-66,000
-2% -$598K
CE icon
1018
Celanese
CE
$4.79B
$25M 0.01%
381,968
-7,546,350
-95% -$524M
CFCOU
1019
DELISTED
CF Corporation
CFCOU
$24.8M 0.01%
+2,501,000
New +$24.9M
WKC icon
1020
World Kinect Corp
WKC
$1.91B
$24.8M 0.01%
521,410
+15,491
+3% +$721K
WBMD
1021
DELISTED
WebMD Health Corp.
WBMD
$24.6M 0.01%
424,010
+30,800
+8% +$1.93M
ISIL
1022
DELISTED
Intersil Corp
ISIL
$24.5M 0.01%
1,811,532
-102,640
-5% -$1.33M
HOT
1023
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$24.5M 0.01%
331,532
-4,120
-1% -$316K
DGX icon
1024
Quest Diagnostics
DGX
$26.2B
$24.5M 0.01%
300,944
-3,012,930
-91% -$229M
MASI
1025
DELISTED
Masimo
MASI
$24.5M 0.01%
466,280
+23,500
+5% +$1.11M

Similar funds

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.